Related Experiment Video
Updated: Nov 4, 2025

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
Published on: May 25, 2018
Gene Editing: How Can You Ask "Whether" If You Don't Know "How"?
Ethical discussions on gene editing are shifting. Research now focuses on *how* to perform gene editing ethically, which is a prerequisite for debating *whether* it should be done.
Area of Science:
- Bioethics
- Gene Editing Technologies
- Translational Science
Background:
- Ethical discourse on gene editing has predominantly focused on permissibility and desirability.
- Existing research on responsible translational pathways for human germline gene editing has faced criticism for addressing secondary concerns.
Purpose of the Study:
- To highlight the primacy of 'how' questions in ethical gene editing discussions.
- To argue that understanding the ethical implementation of gene editing precedes debates on its overall permissibility.
Main Methods:
- Literature review and conceptual analysis of ethical frameworks for gene editing.
- Examination of the relationship between ethical implementation models and permissibility debates.
Main Results:
- The ethical 'how' of gene editing is a foundational question, logically preceding 'whether' questions.
- Developing models for responsible clinical use is essential before assessing desirability and permissibility.
Conclusions:
- Ethical considerations for gene editing necessitate a focus on practical implementation pathways.
- Prioritizing 'how' questions will facilitate more productive ethical debates on gene editing applications.
More Related Videos
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
09:43Author Spotlight: Streamlining Rice Breeding with CRISPR/Cas for Obtaining Optimal Phenotypic and Agronomic Traits
Published on: January 3, 2025
Related Concept Videos
What is Genetic Engineering?
CRISPR
In-vitro Mutagenesis
Gene Therapy
CRISPR/Cas9 Genome Editing
Homologous Recombination